Dr. Logan Discusses Ibrutinib Plus Venetoclax in CLL
March 2nd 2018Aaron Logan, MD, PhD, assistant professor of clinical medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the combination of ibrutinib (Imbruvica) and venetoclax (Venclexta) in chronic lymphocytic leukemia.
Read More